The Treatment of PD-1 Antibody Combined With Peg-IFNα in NAs-suppressed CHB Patients

Exclusion Criteria

• •1. Cirrhosis;
• •2. platelet count \< 90×10\^9/L, WBC count \< 3.0×10\^9/L, neutrophil count \< 1.3×10\^9/L, ALT \> ULN（40U/L）, total bilirubin \> 2ULN;
• •3. History of or suspicion of hepatocellular carcinoma
• •4. Patients received interferon therapy within 12 months;
• •5. Patients received immunosuppressive therapy or other therapy influenced study within 12 months;
• •6. Hepatitis A, hepatitis C, hepatitis D, HIV infection or other active infections;
• •7. Alcohol or drug abuse/dependence;
• •8. Investigator judges that the participants are not suitable for this study.